Cargando…
Balancing efficacy and quality of life measurements among metastatic renal cell carcinoma (RCC) studies
Metastatic renal cell carcinoma (mRCC) treatments have rapidly evolved in the last few years. While vascular endothelial growth factor (VEGF) inhibition had previously been the mainstay of treatment for first-line advanced RCC therapy in the past decade, it has now rapidly changed into combination c...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045961/ https://www.ncbi.nlm.nih.gov/pubmed/33884285 http://dx.doi.org/10.18632/oncoscience.528 |